IDH2 and central nervous system cancer: O6-methylguanine-DNA methyltransferase (MGMT) methylation, 1p/19q co-deletion, IDH, and epidermal growth factor receptor have been widely used as glioma biomarkers (McNamara et al. 2013; Ludwig and Kornblum 2017).